Absence of LKM-1 Antibody Reactivity in Autoimmune and Hepatitis-C-Related Chronic Liver Disease in Sweden

References

• Rizetto M, Swana G, Doniach D. Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol 1973; 15: 331–4
   PubMed Web of Science ®Google Scholar
• Manns M P, Griffin K J, Sullivan K F, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6 a cytochrome P-450 monooxygenase. J Clin Invest 1991; 88: 1370–8
   PubMed Web of Science ®Google Scholar
• Smith M GM, Williams R, Walker G, Rizetto M, Doniach D. Hepatic disorders associated with liver/kidney microsomal antibodies. Br Med J 1974; 2: 80–4
   PubMed Web of Science ®Google Scholar
• Homberg J C, Abuaf N, Bernard O, Islam S, Alvarez F, Khaiil S H. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of ‘autoimmune’ hepatitis. Hepatology 1987; 7: 1333–9
   PubMed Web of Science ®Google Scholar
• Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y. Anti-liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992; 16: 630–6
   PubMed Web of Science ®Google Scholar
• Crivelli O, Lavarini C, Chiaberge E, Amoroso A, Farci P, Negro F. Microsomal autoantibodies in chronic infection with the HBsAg associated delta agent. Clin Exp Immunol 1983; 54: 232–8
   PubMed Web of Science ®Google Scholar
• Todros L, Touscoz G, D'Urso N, Durazzo M, Albano E, Poli G. Hepatitis C-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). J Hepatol 1991; 13: 128–31
   PubMed Web of Science ®Google Scholar
• Lenzi M, Johnson P J, McFarlane I G, Ballardini G, Smith H M, McFarlane B M. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338: 277–80
   PubMed Web of Science ®Google Scholar
• Czaja A J, Carpenter H A, Santrach P J, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 1995; 108: 157–64
   PubMed Web of Science ®Google Scholar
• Michel G, Ritter A, Gerken G, Meyer zum Büchenfelde KH, Decker R, Manns M. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992; 339: 267–9
   PubMed Web of Science ®Google Scholar
• Olsson R, Lindberg J, Weiland O, Nilsson L. Chronic active hepatitis in Sweden. The etiologic spectrum clinical presentation and laboratory profile. Scand J Gastroenterol 1988; 23: 463–70
   PubMed Web of Science ®Google Scholar
• Lindgren S, Eriksson S, Deppner P, Wassmuth R. HLA DR, DO and DP gene polymorphism in Swedish patients with primary biliary cirrhosis. J Hegatol 1995; 23: 128, Suppl 1
   Google Scholar
• Olsson R, Danielsson A, Jämerot G, Lindström E, Lööf L, Rolny P. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. An epidemiological study from five areas in Sweden. Gastroenterology 1991; 100: 1319–23
   PubMed Web of Science ®Google Scholar
• Verbaan H, Andersson K, Eriksson S. Intravenous drug abuse-the major route of hepatitis C virus transmission among alcohol dependent individuals. Scand J Gastroenterol 1993; 28: 714–8
   PubMed Web of Science ®Google Scholar
• Johnson P J, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998–1005
   PubMed Web of Science ®Google Scholar
• Michel G, Braun H-B, Thome-Kromer B, Manns M, Röhrig K. Detection of anti-LKM-1 autoantibodies by microparticle capture enzyme immunoassay. Hepatology 1993; 18: 216, Suppl 2
   PubMed Web of Science ®Google Scholar
• Manns M, Meyer zum Buchenfelde K-H, Slusarczyk J, Dienes HP. Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial anti-bodies in inflammatory liver diseases. Clin Exp Immunol 1984; 57: 600–8
   PubMed Web of Science ®Google Scholar
• Manns M, Johnson E F, Griffin K J, Tan E M, Sullivan KF. The major target of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450dbl. J Clin Invest 1989; 83: 1066–72
   PubMed Web of Science ®Google Scholar
• Garson J A, Lenzi M, Ring C, Cassani F, Ballardini G, Briggs M. Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol 1991; 34: 223–6
   PubMed Web of Science ®Google Scholar
• Alvarez F, Bernard O, Homberg J C, Kreibich G. Anti-liver-kidney microsome antibody recognizes a 50 000 molecular weight protein of the endoplasmic reticulum. J Exp Med 1985; 161: 1231–6
   PubMed Web of Science ®Google Scholar
• Ma Y, Peakman M, Lobo-Yeo A, Wen L, Lenzi M, Gaken J. Differences in immune recognition of cytochrome P450D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection. Clin Exp Immunol 1994; 97: 94–9
   PubMed Web of Science ®Google Scholar
• Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli-Vergani G, Vergani D. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 1995; 37: 406–12
   PubMed Web of Science ®Google Scholar
• Gregersen PK. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease. Lab Invest 1989; 61: 5–19
   PubMed Web of Science ®Google Scholar
• Donaldson P T, Doherty D G, Hayllar K M, McFarlane I G, Johnson P J, Williams R. Susceptibility of autoimmune chronic active hepatitis: human leucocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13: 701–6
   PubMed Web of Science ®Google Scholar
• Burman P, Totterman T H, Öberg K, Karlsson FA. Thyroid autoimmunity in patients on long term therapy with leucocyte-derived interferon. J Clin Endocrinol Metab 1986; 63: 1086–90
   PubMed Web of Science ®Google Scholar
• Fattovich G, Betterle C, Brollo L, Pedini B, Guistina R, Realdi G. Autoantibodies during alpha-interferon therapy for chronic hepatitis B. J Med Virol 1991; 34: 132–5
   PubMed Web of Science ®Google Scholar
• McFarlane B, Bridger C, Tibbs C J, Saleh M G, Fuzio A, Verucchi G. Virus-induced autoimmunity in hepatitis C virus infections: a rare event. J Med Virol 1994; 42: 60–72
   PubMed Web of Science ®Google Scholar